Satsuma Pharmaceuticals Inc (STSA)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
1.1000 -0.0100 (-0.90%) 06/07/23 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 1.1000 unch (unch) -
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -70,055 | -51,172 | -47,563 | -28,175 | -7,346 |
| Depreciation Amortization | 738 | 1,092 | 424 | 146 | 85 |
| Accounts payable and accrued liabilities | 466 | -1,212 | -1,625 | 3,984 | -177 |
| Other Working Capital | 367 | 1,101 | 794 | -2,358 | 295 |
| Other Operating Activity | 16,968 | 7,194 | 5,643 | -3,234 | 162 |
| Operating Cash Flow | $-51,516 | $-42,997 | $-42,327 | $-29,637 | $-6,981 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 43,843 | -48,747 | 63,164 | -95,325 | N/A |
| PPE Investments | -472 | -2,030 | -5,165 | -551 | -402 |
| Investing Cash Flow | $43,371 | $-50,777 | $57,999 | $-95,876 | $-402 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 4,944 |
| Debt Repayment | -1,083 | -2,000 | -2,000 | -167 | N/A |
| Common Stock Issued | 9,822 | 75,283 | 134 | 81,740 | N/A |
| Other Financing Activity | 0 | 0 | -235 | 61,490 | 5,986 |
| Financing Cash Flow | $8,739 | $73,283 | $-2,101 | $143,063 | $10,930 |
| Beginning Cash Position | 15,835 | 36,326 | 22,755 | 5,205 | 1,658 |
| End Cash Position | 16,429 | 15,835 | 36,326 | 22,755 | 5,205 |
| Net Cash Flow | $594 | $-20,491 | $13,571 | $17,550 | $3,547 |
| Free Cash Flow | |||||
| Operating Cash Flow | -51,516 | -42,997 | -42,327 | -29,637 | -6,981 |
| Capital Expenditure | -472 | -2,030 | -5,165 | -551 | -402 |
| Free Cash Flow | -51,988 | -45,027 | -47,492 | -30,188 | -7,383 |